72051722RFA00001: USAID Enhanced HIV Services for Epidemic Control
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Dominican Republic USAID-Santo Domingo notices from 2022.
Dominican Republic USAID-Santo Domingo offered grants of up to $19.1 million to any type of organization. It expected to make one award. Applications closed on May 23, 2022.
From the official notice on Grants.gov, last changed May 16, 2022. Checked November 7, 2026.
- Award ceiling$19.1 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | April 21, 2022 |
|---|---|
| Deadline | May 23, 2022 |
| Archived by Grants.gov | June 22, 2022 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Eligibility for this NOFO is not restricted. Eligible organizations include: registered U.S. and non-U.S. private non-governmental organizations; registered U.S. and non-U.S. non-profit organizations. Types of organizations could include foundations, faith-based organizations (FBOs), community-based organizations (CBOs), private organizations affiliated with public academic institutions and international non-governmental organizations, private companies, professional associations, and other international and indigenous organizations. Local partnership consortiums comprising any of the above are also encouraged to apply.USAID defines a “local entity” as an individual, a corporation, a nonprofit organization, or another body of persons that: 1. Is legally organized under the laws of;2. Has as its principal place of business or operations in;3. Is majority owned by individuals who are citizens or lawful permanent residents of; and4. Is managed by a governing body the majority of who are citizens or lawful permanent residents of the country receiving assistance. For purposes of this section, ‘majority owned’ and ‘managed by’ include, without limitation, beneficiary interests and the power, either directly or indirectly, whether exercised or exercisable, to control the election, appointment, or tenure of the organization's managers or a majority of the organization's governing body by any means. Other U.S. Government departments and agencies may not apply for USAID funding under this NOFO.All applicants must be legally recognized organizational entities under applicable law.
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $19.1 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The purpose of this amendment is to provide answer to questions and modify the NOFO to: On page 41, Annex II: Concept Paper Template, include the notional budget template table under bullet 7. On page 14, under 5.4 delete “https://www.usaid.gov/ads/policy/300/303mbb” and replace with “https://www.usaid.gov/sites/default/files/documents/303.pdf under ADS 303.3.24, Types of Assistance Instruments, Renewal Awards. All other terms and conditions of the USAID Enhanced HIV Services for Epidemic Control NOFO remain unchanged.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72051722RFA00001 still open?
No. It closed on May 23, 2022.
Who can apply for USAID Enhanced HIV Services for Epidemic Control?
Dominican Republic USAID-Santo Domingo accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for USAID Enhanced HIV Services for Epidemic Control?
Closed May 23, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $19.1 million each.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)